Endurance Wealth Management, Inc. Amgen Inc Transaction History

Endurance Wealth Management, Inc.

$731 Million
Q2 2023

A detailed history of Endurance Wealth Management, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Endurance Wealth Management, Inc. holds 1,169 shares of AMGN stock, worth $319,616. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,169

Previous 1,169 -0.0%

Holding current value

$319,616

Previous $283,000 8.13%

% of portfolio

0.04%

Previous 0.04%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 01, 2023	BUY	$229.03 - $291.01 $687 - $873	3 Added 0.26%	1,169 $307,000
Q3 2022 Oct 21, 2022	SELL	$224.46 - $253.15 $6.73 Million - $7.59 Million	-30,000 Reduced 96.26%	1,166 $263,000
Q3 2021 Oct 28, 2021	SELL	$212.27 - $248.7 $21,227 - $24,870	-100 Reduced 0.32%	31,166 $6.63 Million
Q2 2021 Aug 04, 2021	SELL	$233.58 - $259.14 $23,358 - $25,914	-100 Reduced 0.32%	31,266 $7.62 Million
Q3 2020 Oct 27, 2020	SELL	$234.65 - $260.95 $13,140 - $14,613	-56 Reduced 0.18%	31,366 $7.97 Million
Q1 2020 May 11, 2020	BUY	$182.24 - $241.7 $10,205 - $13,535	56 Added 0.18%	31,422 $6.37 Million
Q3 2019 Oct 18, 2019	BUY	$174.11 - $208.62 $88,099 - $105,561	506 Added 1.64%	31,366 $6.07 Million
Q4 2018 Jan 14, 2019	SELL	$178.4 - $208.25 $11,774 - $13,744	-66 Reduced 0.21%	30,860 $6.01 Million
Q3 2018 Oct 10, 2018	SELL	$185.29 - $208.89 $555,870 - $626,670	-3,000 Reduced 8.84%	30,926 $6.41 Million
Q2 2018 Aug 02, 2018	SELL	$166.05 - $186.51 $40,848 - $45,881	-246 Reduced 0.72%	33,926 $6.26 Million
Q1 2018 Apr 19, 2018	SELL	$169.43 - $198.0 $12,707 - $14,850	-75 Reduced 0.22%	34,172 $5.83 Million
Q3 2017 Oct 19, 2017	BUY	$167.29 - $191.0 $5.73 Million - $6.54 Million	34,247	34,247 $6.39 Million

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Endurance Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Endurance Wealth Management, Inc. with notifications on news.

Account

Endurance Wealth Management, Inc. Amgen Inc Transaction History